Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

NCT00115245 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Telbivudine (LdT)
DRUG: Adefovir Dipivoxil

Sponsor

Novartis

Collaborators

[object Object]